In this edition of The Motley Fool's health care show Market Checkup, health care analysts David Williamson and Max Macaluso take a close look at AbbVie, the pharmaceutical company that was spun out of Abbott at the start of the year.
A deep dive into AbbVie, a brand new company with a long history.
David Williamson owns shares of Pfizer. Max Macaluso, Ph.D. owns shares of Gilead Sciences and Celgene. The Motley Fool recommends Celgene and Gilead Sciences. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.